Screening Volunteers for Clinical Trials
Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Jun 16, 2011
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Screening Volunteers for Clinical Trials study is looking for healthy individuals to help researchers learn more about vaccines and how they work. This study is part of a larger effort by the National Institute of Allergy and Infectious Diseases (NIAID) to find volunteers who may qualify for future vaccine trials. If you are between 18 and 60 years old and in good health, you may be eligible to participate.
As a volunteer, you will be asked questions about your health history and undergo a physical exam. Some blood and urine tests may be done to ensure you meet the health requirements for future studies. It's important to know that during this screening, you will not receive any investigational products or vaccines. If you’re interested in contributing to important vaccine research and meet the eligibility criteria, your participation could make a difference in understanding how to better protect people from diseases.
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- • Age: 18 years of age or older
- • Able and willing to complete the informed consent process
- • Agree to have blood and/or tissue samples collected and stored for future studies of investigational products, the immune system, and/or other medical conditions
- EXCLUSION CRITERIA:
- • A condition in which repeated blood draws or injections pose more than minimal risk for the subject such as hemophilia, other severe coagulation disorders or significantly impaired venous access
- • A condition that requires active medical intervention or monitoring to avert serious danger to the participant s health or well-being
- • Known to be pregnant or breast-feeding
About National Institute Of Allergy And Infectious Diseases (Niaid)
The National Institute of Allergy and Infectious Diseases (NIAID) is a key component of the National Institutes of Health (NIH) dedicated to advancing the understanding, prevention, and treatment of infectious and immune-mediated diseases. Through rigorous clinical trials, NIAID aims to foster innovative research that enhances public health and addresses global health challenges, including emerging infectious diseases and allergies. The institute collaborates with various partners, including academic institutions, industry, and international organizations, to translate scientific discoveries into effective therapies and vaccines. NIAID's commitment to high-quality clinical research is integral to improving health outcomes and informing policy decisions in the realm of infectious diseases and immunology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Atlanta, Georgia, United States
Baltimore, Maryland, United States
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Lasonji A Holman, C.R.N.P.
Principal Investigator
National Institute of Allergy and Infectious Diseases (NIAID)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials